# VIA THERAPEUTICS, LLC: Novel Ocular Aerosol Drug Delivery Device for the Treatment Optimization of Glaucoma.

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | VIA THERAPEUTICS, LLC |
| Location | AUSTIN, TX |
| Project | Novel Ocular Aerosol Drug Delivery Device for the Treatment Optimization of Glaucoma. |
| Project number | 1R43EY038569-01 |
| Mechanism | R43 |
| Institute | National Eye Institute |
| Award | $277,143 |
| Awarded | 2026-09-18 |
| Project period | 2026-09-30 to 2027-09-29 |
| UEI | YHRZATLXKL46 |

## Why this score
- Award of $277,143.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11314713). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.